Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development

Evidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in clinical outcome assessment (COA) instrument development. Saturation is described as the point at which no new data is expected to emerge from the conduc...

Full description

Saved in:
Bibliographic Details
Published inValue in health Vol. 21; no. 7; pp. 839 - 842
Main Authors Turner-Bowker, Diane M., Lamoureux, Roger E., Stokes, Jonathan, Litcher-Kelly, Leighann, Galipeau, Nina, Yaworsky, Andrew, Solomon, Jeffrey, Shields, Alan L.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2018
Elsevier Science Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Evidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in clinical outcome assessment (COA) instrument development. Saturation is described as the point at which no new data is expected to emerge from the conduct of additional qualitative interviews. A retrospective evaluation of 26 CE interview studies conducted with patients between 2006 and 2013 was completed to assess the point at which saturation of concept was achieved in each study. For each of the 26 interview studies, saturation of symptom concepts was assessed by dividing the sample into quartiles and then comparing the number of responses elicited from the first 25% of participants to the next 25% of participants, from the first 50% of participants to the next 25% of participants, and then from the first 75% of participants to the last 25% of participants. The number of interviews required to achieve saturation was documented for each study and then summarized across studies. Findings indicate that 84% of symptom concepts emerged by the 10th interview, 92% emerged by the 15th interview, 97% emerged by the 20th interview, and 99% by the 25th interview. Results provide practical guidance for estimating the number of interviews that may be needed to achieve saturation in a qualitative CE interview study for COA instrument development; address an important gap in qualitative research for the development of COAs in the context of medical product development; and offer useful information for study design and implementation.
AbstractList Evidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in clinical outcome assessment (COA) instrument development. Saturation is described as the point at which no new data is expected to emerge from the conduct of additional qualitative interviews. A retrospective evaluation of 26 CE interview studies conducted with patients between 2006 and 2013 was completed to assess the point at which saturation of concept was achieved in each study. For each of the 26 interview studies, saturation of symptom concepts was assessed by dividing the sample into quartiles and then comparing the number of responses elicited from the first 25% of participants to the next 25% of participants, from the first 50% of participants to the next 25% of participants, and then from the first 75% of participants to the last 25% of participants. The number of interviews required to achieve saturation was documented for each study and then summarized across studies. Findings indicate that 84% of symptom concepts emerged by the 10th interview, 92% emerged by the 15th interview, 97% emerged by the 20th interview, and 99% by the 25th interview. Results provide practical guidance for estimating the number of interviews that may be needed to achieve saturation in a qualitative CE interview study for COA instrument development; address an important gap in qualitative research for the development of COAs in the context of medical product development; and offer useful information for study design and implementation.
Objective Evidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in clinical outcome assessment (COA) instrument development. Saturation is described as the point at which no new data is expected to emerge from the conduct of additional qualitative interviews. Study Design A retrospective evaluation of 26 CE interview studies conducted with patients between 2006 and 2013 was completed to assess the point at which saturation of concept was achieved in each study. Methods For each of the 26 interview studies, saturation of symptom concepts was assessed by dividing the sample into quartiles and then comparing the number of responses elicited from the first 25% of participants to the next 25% of participants, from the first 50% of participants to the next 25% of participants, and then from the first 75% of participants to the last 25% of participants. The number of interviews required to achieve saturation was documented for each study and then summarized across studies. Results Findings indicate that 84% of symptom concepts emerged by the 10th interview, 92% emerged by the 15th interview, 97% emerged by the 20th interview, and 99% by the 25th interview. Conclusions Results provide practical guidance for estimating the number of interviews that may be needed to achieve saturation in a qualitative CE interview study for COA instrument development; address an important gap in qualitative research for the development of COAs in the context of medical product development; and offer useful information for study design and implementation.
Evidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in clinical outcome assessment (COA) instrument development. Saturation is described as the point at which no new data is expected to emerge from the conduct of additional qualitative interviews.OBJECTIVEEvidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in clinical outcome assessment (COA) instrument development. Saturation is described as the point at which no new data is expected to emerge from the conduct of additional qualitative interviews.A retrospective evaluation of 26 CE interview studies conducted with patients between 2006 and 2013 was completed to assess the point at which saturation of concept was achieved in each study.STUDY DESIGNA retrospective evaluation of 26 CE interview studies conducted with patients between 2006 and 2013 was completed to assess the point at which saturation of concept was achieved in each study.For each of the 26 interview studies, saturation of symptom concepts was assessed by dividing the sample into quartiles and then comparing the number of responses elicited from the first 25% of participants to the next 25% of participants, from the first 50% of participants to the next 25% of participants, and then from the first 75% of participants to the last 25% of participants. The number of interviews required to achieve saturation was documented for each study and then summarized across studies.METHODSFor each of the 26 interview studies, saturation of symptom concepts was assessed by dividing the sample into quartiles and then comparing the number of responses elicited from the first 25% of participants to the next 25% of participants, from the first 50% of participants to the next 25% of participants, and then from the first 75% of participants to the last 25% of participants. The number of interviews required to achieve saturation was documented for each study and then summarized across studies.Findings indicate that 84% of symptom concepts emerged by the 10th interview, 92% emerged by the 15th interview, 97% emerged by the 20th interview, and 99% by the 25th interview.RESULTSFindings indicate that 84% of symptom concepts emerged by the 10th interview, 92% emerged by the 15th interview, 97% emerged by the 20th interview, and 99% by the 25th interview.Results provide practical guidance for estimating the number of interviews that may be needed to achieve saturation in a qualitative CE interview study for COA instrument development; address an important gap in qualitative research for the development of COAs in the context of medical product development; and offer useful information for study design and implementation.CONCLUSIONSResults provide practical guidance for estimating the number of interviews that may be needed to achieve saturation in a qualitative CE interview study for COA instrument development; address an important gap in qualitative research for the development of COAs in the context of medical product development; and offer useful information for study design and implementation.
Author Galipeau, Nina
Shields, Alan L.
Yaworsky, Andrew
Stokes, Jonathan
Litcher-Kelly, Leighann
Lamoureux, Roger E.
Solomon, Jeffrey
Turner-Bowker, Diane M.
Author_xml – sequence: 1
  givenname: Diane M.
  surname: Turner-Bowker
  fullname: Turner-Bowker, Diane M.
  email: diane.turner-bowker@adelphivalues.com
  organization: Adelphi Values, Boston, MA, USA
– sequence: 2
  givenname: Roger E.
  surname: Lamoureux
  fullname: Lamoureux, Roger E.
  organization: Adelphi Values, Boston, MA, USA
– sequence: 3
  givenname: Jonathan
  surname: Stokes
  fullname: Stokes, Jonathan
  organization: Adelphi Values, Boston, MA, USA
– sequence: 4
  givenname: Leighann
  surname: Litcher-Kelly
  fullname: Litcher-Kelly, Leighann
  organization: Adelphi Values, Boston, MA, USA
– sequence: 5
  givenname: Nina
  surname: Galipeau
  fullname: Galipeau, Nina
  organization: Adelphi Values, Boston, MA, USA
– sequence: 6
  givenname: Andrew
  surname: Yaworsky
  fullname: Yaworsky, Andrew
  organization: Adelphi Values, Boston, MA, USA
– sequence: 7
  givenname: Jeffrey
  surname: Solomon
  fullname: Solomon, Jeffrey
  organization: Independent research and evaluation consultant, Boston, MA, USA
– sequence: 8
  givenname: Alan L.
  surname: Shields
  fullname: Shields, Alan L.
  organization: Adelphi Values, Boston, MA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30005756$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9uEzEYxC1URNvAC3BAlrj0sou9zv5DXKoQIFKlCgXOltf-Fnnx2sH2BpX34H3xNsklh3Ly2JrfyJq5RhfWWUDoNSU5JbR6N-TDXpi8ILTOKc0JXT5DV7QsltmyZuwiadI2GSO0vETXIQyEkIoV5Qt0yZIs67K6Qn83tnd-1PYHFnjntfMab8W4M4C3-g_gdYh6FFE7i7XFXydhdEzXPeCVsxJ2Ea-Nlo9vybKxEfxew2-8jZPSEHAKxyujrZbC4PspSjcCvg0BQhjBxkSE6KdH-RH2YNxu1i_R816YAK-O5wJ9_7T-tvqS3d1_3qxu7zJZEhozSUTTs6pTfcNKKqiqBVNKlH3J6q5i0ItWlC3rJMhWVHUNbdOIqhNdp1RPFGULdHPI3Xn3a4IQ-aiDBGOEBTcFXpCaFBWlqc4FentmHdzkbfpdcjU0lbks5sA3R9fUjaB4anQU_oGfCk-G5mCQ3oXgoeen8qIX2nBK-LwtH_i8LZ-35ZTytG1CizP0lP4k9OEAQaoxLeN5kBrSckp7kJErp5_G35_h8jjmT3j4H_wPfzTUkw
CitedBy_id crossref_primary_10_3168_jds_2020_18552
crossref_primary_10_1007_s40257_020_00545_9
crossref_primary_10_1089_cap_2018_0089
crossref_primary_10_1186_s41687_023_00605_8
crossref_primary_10_1007_s13555_020_00474_9
crossref_primary_10_1111_bjd_19024
crossref_primary_10_1007_s40271_021_00539_7
crossref_primary_10_1186_s41687_023_00624_5
crossref_primary_10_1371_journal_pone_0280259
crossref_primary_10_3390_ijerph191912349
crossref_primary_10_1007_s11136_023_03524_9
crossref_primary_10_1371_journal_pone_0305754
crossref_primary_10_1007_s40121_021_00581_w
crossref_primary_10_1111_dmcn_15485
crossref_primary_10_1007_s12325_022_02172_8
crossref_primary_10_1007_s41030_024_00263_1
crossref_primary_10_1111_dmcn_15486
crossref_primary_10_1186_s41687_022_00471_w
crossref_primary_10_1007_s13555_023_00968_2
crossref_primary_10_1007_s40123_023_00860_4
crossref_primary_10_1186_s41687_021_00321_1
crossref_primary_10_1007_s12325_023_02443_y
crossref_primary_10_1111_nmo_14960
crossref_primary_10_1093_ptj_pzae132
crossref_primary_10_1016_j_jpedsurg_2020_06_041
crossref_primary_10_1007_s40123_023_00751_8
crossref_primary_10_1111_phn_13059
crossref_primary_10_3390_children10010073
crossref_primary_10_1080_13696998_2024_2395164
crossref_primary_10_1186_s41687_020_00277_8
crossref_primary_10_1186_s41687_020_00235_4
crossref_primary_10_1186_s41687_023_00666_9
crossref_primary_10_1007_s00431_023_05285_6
crossref_primary_10_1007_s10488_024_01363_5
crossref_primary_10_1016_j_puhip_2021_100221
crossref_primary_10_1371_journal_pone_0316796
crossref_primary_10_1186_s12904_025_01680_y
crossref_primary_10_1007_s13300_023_01426_0
crossref_primary_10_1097_NCC_0000000000001438
crossref_primary_10_1186_s41687_022_00461_y
crossref_primary_10_1186_s41687_023_00673_w
crossref_primary_10_1111_irv_12929
crossref_primary_10_1093_ptj_pzab025
crossref_primary_10_1007_s40123_021_00391_w
crossref_primary_10_1186_s41687_022_00413_6
crossref_primary_10_1177_00178969221079587
crossref_primary_10_1007_s40271_021_00501_7
crossref_primary_10_1007_s40487_021_00159_z
crossref_primary_10_1186_s12890_024_03442_7
crossref_primary_10_1186_s12955_021_01888_5
crossref_primary_10_1016_j_jsxm_2020_07_010
crossref_primary_10_1016_j_clgc_2024_102209
crossref_primary_10_1186_s41687_020_00246_1
crossref_primary_10_1007_s11136_022_03297_7
crossref_primary_10_1080_07853890_2022_2105393
crossref_primary_10_2217_fon_2021_0773
crossref_primary_10_3390_ijerph192315712
crossref_primary_10_1007_s40271_022_00591_x
crossref_primary_10_1016_j_dajour_2023_100337
crossref_primary_10_1007_s13555_022_00752_8
crossref_primary_10_1016_j_jtocrr_2021_100198
crossref_primary_10_1186_s41687_021_00409_8
crossref_primary_10_3390_ijerph18115598
crossref_primary_10_3390_ijerph191710524
crossref_primary_10_1007_s11136_021_02847_9
crossref_primary_10_1007_s40271_021_00552_w
crossref_primary_10_1016_j_jaip_2022_02_049
crossref_primary_10_1093_jac_dkae453
crossref_primary_10_1007_s11136_019_02233_6
crossref_primary_10_1007_s11136_021_02903_4
crossref_primary_10_1186_s41687_020_00273_y
crossref_primary_10_1016_j_heliyon_2024_e39688
crossref_primary_10_1016_j_jbtep_2022_101753
crossref_primary_10_3390_ijerph18010127
crossref_primary_10_1097_GME_0000000000001275
crossref_primary_10_1080_09638288_2023_2237403
crossref_primary_10_1186_s40834_018_0075_8
crossref_primary_10_2147_OPTH_S496201
crossref_primary_10_1186_s41687_022_00506_2
crossref_primary_10_1080_03007995_2018_1560222
crossref_primary_10_1007_s40120_022_00408_x
crossref_primary_10_1097_GOX_0000000000003522
crossref_primary_10_1186_s13023_019_1200_8
crossref_primary_10_1093_ptj_pzae043
crossref_primary_10_1186_s41687_023_00675_8
crossref_primary_10_1186_s12890_022_02171_z
crossref_primary_10_1177_10436596241297984
crossref_primary_10_1016_j_jaip_2024_08_030
crossref_primary_10_1002_nop2_1121
crossref_primary_10_23736_S1973_9087_19_05474_1
crossref_primary_10_1111_bjd_18883
crossref_primary_10_1007_s40271_024_00726_2
crossref_primary_10_3390_ijerph18168368
crossref_primary_10_1007_s40744_022_00493_2
crossref_primary_10_1007_s40271_024_00677_8
crossref_primary_10_3390_ijerph17207500
crossref_primary_10_1101_cshperspect_a041298
crossref_primary_10_1097_CND_0000000000000303
crossref_primary_10_1007_s12325_024_02846_5
crossref_primary_10_1186_s12885_025_13474_9
crossref_primary_10_1080_07853890_2023_2255215
crossref_primary_10_1186_s13023_021_02035_5
crossref_primary_10_3233_JPD_202457
crossref_primary_10_1111_head_14484
crossref_primary_10_1016_j_dib_2020_106106
crossref_primary_10_1186_s12874_024_02288_1
crossref_primary_10_1017_S146342362200038X
crossref_primary_10_1136_bmjopen_2022_068561
crossref_primary_10_1111_apt_15726
crossref_primary_10_2196_52998
crossref_primary_10_1007_s10461_021_03357_y
crossref_primary_10_1111_head_14274
crossref_primary_10_1186_s41687_024_00712_0
crossref_primary_10_1186_s41687_020_00240_7
crossref_primary_10_5334_ijic_6526
crossref_primary_10_1007_s00520_022_07054_x
crossref_primary_10_1002_cam4_4955
crossref_primary_10_1177_17534666241274261
crossref_primary_10_1016_j_anai_2020_07_027
crossref_primary_10_1093_ibd_izae044
crossref_primary_10_1136_bmjopen_2024_089319
crossref_primary_10_1186_s41687_019_0098_1
crossref_primary_10_3390_su132212611
crossref_primary_10_1186_s41687_023_00610_x
crossref_primary_10_1016_j_socscimed_2021_114523
crossref_primary_10_1371_journal_pone_0234898
crossref_primary_10_1111_head_14664
crossref_primary_10_1007_s40123_023_00667_3
crossref_primary_10_3389_fvets_2024_1377019
crossref_primary_10_1016_j_ymgmr_2021_100810
Cites_doi 10.1016/j.jclinepi.2016.10.001
10.1080/08870440903194015
10.1016/j.clinthera.2016.03.012
10.1111/jan.12163
10.1007/s40271-013-0022-3
10.1371/journal.pone.0181689
10.1111/j.1524-4733.2009.00603.x
10.1007/s40271-013-0026-z
10.1016/j.jval.2013.04.004
10.1177/1525822X05279903
10.1016/j.jval.2011.06.014
ContentType Journal Article
Copyright 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Copyright © 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Science Ltd. Jul 2018
Copyright_xml – notice: 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
– notice: Copyright © 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Science Ltd. Jul 2018
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7X8
DOI 10.1016/j.jval.2017.11.014
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Applied Social Sciences Index & Abstracts (ASSIA)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Applied Social Sciences Index and Abstracts (ASSIA)
MEDLINE - Academic
DatabaseTitleList

Applied Social Sciences Index and Abstracts (ASSIA)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1524-4733
EndPage 842
ExternalDocumentID 30005756
10_1016_j_jval_2017_11_014
S1098301518301967
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.3N
.FO
.GA
.Y3
.~1
0R~
10A
123
1OC
1P~
1~.
29Q
31~
36B
4.4
44B
457
4G.
51W
51X
52N
52P
52R
52S
52X
53G
5LA
5VS
66C
6PF
7-5
7PT
8-1
8P~
8UM
AAEDT
AAEDW
AAFJI
AAFWJ
AAIKJ
AAKOC
AALRI
AAMMB
AAOAW
AAPFB
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABCQN
ABDBF
ABEML
ABIVO
ABJNI
ABMAC
ABMMH
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACHQT
ACIEU
ACPRK
ACRLP
ACRPL
ACUHS
ACVFH
ACXQS
ADBBV
ADCNI
ADEZE
ADFHU
ADMUD
ADNMO
ADVLN
AEBSH
AEFGJ
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AEYQN
AFBPY
AFEBI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AFZJQ
AGCQF
AGHFR
AGQPQ
AGTHC
AGUBO
AGXDD
AGYEJ
AIDQK
AIDYY
AIEXJ
AIGII
AIIAU
AIIUN
AIKHN
AITUG
AJAOE
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AOMHK
APXCP
ASPBG
AVARZ
AVWKF
AXJTR
AXLSJ
AZFZN
BAWUL
BFHJK
BKOJK
BLXMC
BNPGV
BY8
CAG
CO8
COF
CS3
DCZOG
DIK
DU5
EAD
EAP
EBS
EFJIC
EFKBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
HF~
HVGLF
HZI
HZ~
IHE
IXB
KOM
LH4
M41
MO0
N9A
O-L
O9-
OAUVE
OIG
OK1
OVD
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
QB0
R2-
ROL
SDF
SEL
SES
SPCBC
SSB
SSF
SSH
SSO
SSZ
SV3
T5K
TEORI
TUS
W99
WIN
WYUIH
XG1
YFH
Z5R
~G-
6I.
AACTN
AAFTH
AAHHS
AAIAV
ABLVK
ABVKL
ABYKQ
ACCFJ
AEEZP
AEQDE
AFCTW
AFKWA
AIWBW
AJBDE
AJBFU
AJOXV
AKYCK
AMFUW
EFLBG
IXIXF
LCYCR
NCXOZ
RIG
SUPJJ
AAYXX
AGRNS
CITATION
0SF
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7X8
ID FETCH-LOGICAL-c501t-c0a8f36bdf8351a1d7a3dda5f537b63efa9a593bcec9a677e988a6babbddf0d13
IEDL.DBID IXB
ISSN 1098-3015
1524-4733
IngestDate Thu Jul 10 20:42:56 EDT 2025
Wed Aug 13 06:21:29 EDT 2025
Wed Feb 19 02:43:34 EST 2025
Tue Jul 01 04:02:41 EDT 2025
Thu Apr 24 23:04:58 EDT 2025
Fri Feb 23 02:27:44 EST 2024
Tue Aug 26 16:33:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords clinical outcome assessment
sample size
concept elicitation interview
saturation of concept
Language English
License This article is made available under the Elsevier license.
Copyright © 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c501t-c0a8f36bdf8351a1d7a3dda5f537b63efa9a593bcec9a677e988a6babbddf0d13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1098301518301967
PMID 30005756
PQID 2081756421
PQPubID 105593
PageCount 4
ParticipantIDs proquest_miscellaneous_2070261173
proquest_journals_2081756421
pubmed_primary_30005756
crossref_citationtrail_10_1016_j_jval_2017_11_014
crossref_primary_10_1016_j_jval_2017_11_014
elsevier_sciencedirect_doi_10_1016_j_jval_2017_11_014
elsevier_clinicalkey_doi_10_1016_j_jval_2017_11_014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2018
2018-07-00
20180701
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: July 2018
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Lawrenceville
PublicationTitle Value in health
PublicationTitleAlternate Value Health
PublicationYear 2018
Publisher Elsevier Inc
Elsevier Science Ltd
Publisher_xml – name: Elsevier Inc
– name: Elsevier Science Ltd
References Arbuckle, Abetz-Webb (bib7) 2013; 6
Mason (bib10) 2010; 11
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, et al. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009.
Glaser, Strauss (bib8) 1967
Francis, Johnston, Robertson (bib16) 2010; 25
Fusch, Ness (bib12) 2015; 20
van Rijnsoever (bib15) 2017; 12
Nunnally, Bernstein (bib1) 1994
Patrick, Burke, Gwaltney (bib2) 2011; 14
.
Tran, Porcher, Tran, Ravaud (bib14) 2017; 82
Matza, Patrick, Riley (bib3) 2013; 16
Guest, Bunce, Johnson (bib11) 2006; 18
Cleary, Horsfall, Hayter (bib13) 2014; 70
Stokes, Evans, Pompilus (bib6) 2013; 6
Rothman, Burke, Erickson (bib9) 2009; 12
McCarrier, Atkinson, DeBusk (bib5) 2016; 38
Matza (10.1016/j.jval.2017.11.014_bib3) 2013; 16
van Rijnsoever (10.1016/j.jval.2017.11.014_bib15) 2017; 12
Nunnally (10.1016/j.jval.2017.11.014_bib1) 1994
10.1016/j.jval.2017.11.014_bib4
Arbuckle (10.1016/j.jval.2017.11.014_bib7) 2013; 6
Patrick (10.1016/j.jval.2017.11.014_bib2) 2011; 14
Cleary (10.1016/j.jval.2017.11.014_bib13) 2014; 70
Francis (10.1016/j.jval.2017.11.014_bib16) 2010; 25
Fusch (10.1016/j.jval.2017.11.014_bib12) 2015; 20
Rothman (10.1016/j.jval.2017.11.014_bib9) 2009; 12
Stokes (10.1016/j.jval.2017.11.014_bib6) 2013; 6
Tran (10.1016/j.jval.2017.11.014_bib14) 2017; 82
Guest (10.1016/j.jval.2017.11.014_bib11) 2006; 18
Glaser (10.1016/j.jval.2017.11.014_bib8) 1967
McCarrier (10.1016/j.jval.2017.11.014_bib5) 2016; 38
Mason (10.1016/j.jval.2017.11.014_bib10) 2010; 11
References_xml – year: 1994
  ident: bib1
  publication-title: Psychometric Theory
– year: 1967
  ident: bib8
  article-title: The Discovery of Grounded Theory: Strategies for Qualitative Research
– volume: 70
  start-page: 473
  year: 2014
  end-page: 475
  ident: bib13
  article-title: Data collection and sampling in qualitative research: does size matter?
  publication-title: J Adv Nurs
– volume: 11
  year: 2010
  ident: bib10
  article-title: Sample size and saturation in PhD studies using qualitative interviews. Forum Qualitative Sozialforschung/Forum. Qual
  publication-title: Soc Res
– volume: 14
  start-page: 967
  year: 2011
  end-page: 977
  ident: bib2
  article-title: Content validity-establishing and reporting the evidence in newly developed Patient-Reported Outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—eliciting concepts for a new PRO instrument
  publication-title: Value Health
– volume: 38
  start-page: 794
  year: 2016
  end-page: 810
  ident: bib5
  article-title: Qualitative development and content validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): a patient-reported outcome instrument
  publication-title: Clin Ther
– volume: 6
  start-page: 291
  year: 2013
  end-page: 305
  ident: bib6
  article-title: Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials
  publication-title: Patient
– volume: 82
  start-page: 71
  year: 2017
  end-page: 78
  ident: bib14
  article-title: Predicting data saturation in qualitative surveys with mathematical models from ecological research
  publication-title: J Clin Epidemiol
– reference: .
– volume: 20
  start-page: 1408
  year: 2015
  end-page: 1416
  ident: bib12
  article-title: Are we there yet? Data saturation in qualitative research
  publication-title: Qual Rep
– volume: 25
  start-page: 1229
  year: 2010
  end-page: 1245
  ident: bib16
  article-title: What is an adequate sample size? Operationalising data saturation for theory-based interview studies
  publication-title: Psychol Health
– volume: 12
  start-page: 1075
  year: 2009
  end-page: 1083
  ident: bib9
  article-title: Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report
  publication-title: Value Health
– volume: 18
  start-page: 59
  year: 2006
  end-page: 82
  ident: bib11
  article-title: How many interviews are enough? An experiment with data saturation and variability
  publication-title: Field Methods
– volume: 12
  start-page: e0181689
  year: 2017
  ident: bib15
  article-title: (I Can’t Get No) saturation: a simulation and guidelines for sample sizes in qualitative research
  publication-title: PLoS One
– volume: 16
  start-page: 461
  year: 2013
  end-page: 479
  ident: bib3
  article-title: Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force
  publication-title: Value Health
– volume: 6
  start-page: 143
  year: 2013
  end-page: 159
  ident: bib7
  article-title: “Not just little adults”: qualitative methods to support the development of pediatric patient-reported outcomes
  publication-title: Patient
– reference: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, et al. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009.
– volume: 82
  start-page: 71
  year: 2017
  ident: 10.1016/j.jval.2017.11.014_bib14
  article-title: Predicting data saturation in qualitative surveys with mathematical models from ecological research
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2016.10.001
– volume: 25
  start-page: 1229
  year: 2010
  ident: 10.1016/j.jval.2017.11.014_bib16
  article-title: What is an adequate sample size? Operationalising data saturation for theory-based interview studies
  publication-title: Psychol Health
  doi: 10.1080/08870440903194015
– volume: 38
  start-page: 794
  year: 2016
  ident: 10.1016/j.jval.2017.11.014_bib5
  article-title: Qualitative development and content validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): a patient-reported outcome instrument
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2016.03.012
– year: 1994
  ident: 10.1016/j.jval.2017.11.014_bib1
– volume: 70
  start-page: 473
  year: 2014
  ident: 10.1016/j.jval.2017.11.014_bib13
  article-title: Data collection and sampling in qualitative research: does size matter?
  publication-title: J Adv Nurs
  doi: 10.1111/jan.12163
– volume: 6
  start-page: 143
  year: 2013
  ident: 10.1016/j.jval.2017.11.014_bib7
  article-title: “Not just little adults”: qualitative methods to support the development of pediatric patient-reported outcomes
  publication-title: Patient
  doi: 10.1007/s40271-013-0022-3
– volume: 20
  start-page: 1408
  year: 2015
  ident: 10.1016/j.jval.2017.11.014_bib12
  article-title: Are we there yet? Data saturation in qualitative research
  publication-title: Qual Rep
– volume: 12
  start-page: e0181689
  year: 2017
  ident: 10.1016/j.jval.2017.11.014_bib15
  article-title: (I Can’t Get No) saturation: a simulation and guidelines for sample sizes in qualitative research
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0181689
– ident: 10.1016/j.jval.2017.11.014_bib4
– year: 1967
  ident: 10.1016/j.jval.2017.11.014_bib8
– volume: 12
  start-page: 1075
  year: 2009
  ident: 10.1016/j.jval.2017.11.014_bib9
  article-title: Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2009.00603.x
– volume: 11
  year: 2010
  ident: 10.1016/j.jval.2017.11.014_bib10
  article-title: Sample size and saturation in PhD studies using qualitative interviews. Forum Qualitative Sozialforschung/Forum. Qual
  publication-title: Soc Res
– volume: 6
  start-page: 291
  year: 2013
  ident: 10.1016/j.jval.2017.11.014_bib6
  article-title: Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials
  publication-title: Patient
  doi: 10.1007/s40271-013-0026-z
– volume: 16
  start-page: 461
  year: 2013
  ident: 10.1016/j.jval.2017.11.014_bib3
  article-title: Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force
  publication-title: Value Health
  doi: 10.1016/j.jval.2013.04.004
– volume: 18
  start-page: 59
  year: 2006
  ident: 10.1016/j.jval.2017.11.014_bib11
  article-title: How many interviews are enough? An experiment with data saturation and variability
  publication-title: Field Methods
  doi: 10.1177/1525822X05279903
– volume: 14
  start-page: 967
  year: 2011
  ident: 10.1016/j.jval.2017.11.014_bib2
  article-title: Content validity-establishing and reporting the evidence in newly developed Patient-Reported Outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—eliciting concepts for a new PRO instrument
  publication-title: Value Health
  doi: 10.1016/j.jval.2011.06.014
SSID ssj0006325
Score 2.5548093
Snippet Evidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in clinical...
Objective Evidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 839
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Child
Clinical assessment
clinical outcome assessment
Clinical outcomes
concept elicitation interview
Concept Formation
Concepts
Elicitation
Estimates
Female
Humans
Interviews as Topic
Male
Middle Aged
Patient Outcome Assessment
Patients
Qualitative Research
Research Subjects - psychology
Retrospective Studies
Sample Size
Saturation
saturation of concept
Surveys and Questionnaires
Young Adult
Title Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1098301518301967
https://dx.doi.org/10.1016/j.jval.2017.11.014
https://www.ncbi.nlm.nih.gov/pubmed/30005756
https://www.proquest.com/docview/2081756421
https://www.proquest.com/docview/2070261173
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED66DsZextb9ytaFG4y-rG6syLLsxyykpBvtCmkhb0ayJXAJSWjTh-6h_0X_350s2d0e2sFejG1Jtuw73Z2t-z4BfLGa8SwZykin1kSJlnGUx6WNrOIlmUJZCuHwzscn6fQ8-T4X8y0Yt1gYl1YZbL-36Y21DmcG4W0O1nU9mLE4z0g9BXPbPHWIcp5kDYhv_q2zxilvFl51lSNXOwBnfI7XBUnTpXfJA8fkyZKHnNNDwWfjhA5fwosQPeLId_AVbJnlDjw7DvPjO7B36pmob_bx7B5YdbWPe3h6z1F98xruPAyJ_BYqXF_Wq8saZ8oxBeOs_mVwQiPfgxqxXqIn2mgownHscY44WdA9_Tw-Nr8V3RwDhrREpItjoBxd4M_rDb1eg6OOBRSPGuLaZvePtKU3cH44ORtPo7BCQ1SKmG2iMlaZ5amuLAVyTLFKKl5VSljBpU65sSpXIue6NGWuUilNnmUq1UrrqrJxxfhb2F6uluY9YJpYqYaqVENpk1iTCxnmCdPKKptTWCJ6wFrRFO3juVU0FkWbp3ZROHEWTpz0XVOQOHvwtWuz9uQdj9bmrcSLFpZKhrQg3_JoK9G1-ktx_9lut1WqIpiNKyrPKJxz2OMefO6KacC7WRy1NKtrV0e672YmeQ_eeWXsHo67EJwu8OE_O_URntNR5tORd2GbNMF8oqBro_vw5OCW9eHp6OjH9KTfjLHffb0wsg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbGkICXCcavwoBDQnthWeM6tpPHUXVqYR2T2kl9i-zEljJVabV1D9v_wf_LOXYyeNiQeImi2E5i3_nuEt_3mZAvVlOWJgMZaWFNlGgZR1lc2MgqVqAplAXnDu88PRXj8-T7gi-2yLDFwri0ymD7vU1vrHW40g-j2V9XVX9G4yxF9eTUHTMhH5HHGA1It3_DZPGtM8eCNTuvutqRqx6QMz7J6wLF6fK75KGj8qTJfd7pvuiz8ULHz8lOCB_hyL_hC7Jl6l3yZBoWyHfJ_pmnor45gPkdsurqAPbh7I6k-uYl-eVxSOi4QMH6slpdVjBTjioYZtWtgRFOfY9qhKoGz7TRcITD0AMdYbTEZ_qFfGj-K7pFBgh5iYA3h8A5uoSf1xscXwNHHQ0oTBrm2ub0j7ylV-T8eDQfjqOwRUNU8JhuoiJWqWVClxYjOapoKRUrS8UtZ1ILZqzKFM-YLkyRKSGlydJUCa20Lksbl5S9Jtv1qjZvCYjESjVQhRpIm8QafcggS6hWVtkM4xLeI7QVTd52z22jsczbRLWL3Ikzd-LED5scxdkjX7s2a8_e8WBt1ko8b3GpaElzdC4PtuJdq78095_t9lqlyoPduMLyFOM5Bz7ukc9dMc54t4yjarO6dnWk-3CmkvXIG6-MXeeYi8HxBu_-86U-kafj-fQkP5mc_nhPnmFJ6nOT98g2aoX5gBHYRn9sZthvCi4xRQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Informing+a+priori+Sample+Size+Estimation+in+Qualitative+Concept+Elicitation+Interview+Studies+for+Clinical+Outcome+Assessment+Instrument+Development&rft.jtitle=Value+in+health&rft.au=Turner-Bowker%2C+Diane+M.&rft.au=Lamoureux%2C+Roger+E.&rft.au=Stokes%2C+Jonathan&rft.au=Litcher-Kelly%2C+Leighann&rft.date=2018-07-01&rft.issn=1098-3015&rft.volume=21&rft.issue=7&rft.spage=839&rft.epage=842&rft_id=info:doi/10.1016%2Fj.jval.2017.11.014&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jval_2017_11_014
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-3015&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-3015&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-3015&client=summon